Ryoji Hirose
Mitsubishi
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ryoji Hirose.
Bioorganic & Medicinal Chemistry Letters | 1995
Tetsuro Fujita; Masahiko Yoneta; Ryoji Hirose; Shigeo Sasaki; Kenichiro Inoue; Masatoshi Kiuchi; Susumu Hirase; Kunitomo Adachi; Masafumi Arita; Kenji Chiba
Abstract ISP-I (myriocin, thermozymocidin) was structurally simplified to give 2-amino-2-alkyl-1,3-propanediols that were also potent immunosuppressants. Among the series, 2-amino-2-pentadecyl-1,3-propanediol most actively prolonged rat skin allograft survival and was more effective than ciclosporin.
Bioorganic & Medicinal Chemistry Letters | 1996
Ryoji Hirose; Norimitsu Hamamichi; Yuuki Kitao; Tohru Matsuzaki; Kenji Yoshitomi Pharmac. Ind. Ltd Chiba; Tetsuro Fujita
Abstract The 2-aminoalcohol series of immunosuppressants showed a bell-shaped relationship between the activity and the carbon number. The ( R )-isomers were more potent than the ( S )-isomers, and ( R )-2-aminohexadecanol displayed comparably activity to a potent immunosuppressant, FTY720.
Bioorganic & Medicinal Chemistry Letters | 1995
Tetsuro Fujita; Ryoji Hirose; Norimitsu Hamamichi; Yuuki Kitao; Shigeo Sasaki; Masahiko Yoneta; Kenji Chiba
Abstract 2-Substituted 2-aminoethanol was shown to be the minimum essential structure for the immunosuppressive activity of ISP-i (myriocin, thermozymocidin) by simplification of 2-substituted 2-amino-1,3-propanediol, which was generated by modification of ISP-I. Among the series, 2-amino-4-(4-octylphenyl)butanol hydrochloride displayed comparably potent activity to 2-amino-2-[2-(4-octylphenyl)ethyl]-1,3-propanediol hydrochloride, FTY720.
Bioorganic & Medicinal Chemistry Letters | 2000
Tetsuro Fujita; Norimasa Matsumoto; Shuji Uchida; Takeyuki Kohno; Takaaki Shimizu; Ryoji Hirose; Kazuo Yanada; Wasako Kurio; Kazuhito Watabe
An antibody was prepared by immunizing rabbits with an ovalbumin conjugate of 2-amino-2-(2-(4-(4-mercaptobutyl)phenyl)ethyl)propane-1,3-diol HCl (AMPD-4), which contains the essential structure of the novel immunosuppressant FTY720. As the antibody reacted to not only AMPD-4, but also FTY720, it should be useful for immunoassay of FTY720 in body fluids, tissues and cells.
Journal of Medicinal Chemistry | 1996
Tetsuro Fujita; Ryoji Hirose; Masahiko Yoneta; Shigeo Sasaki; Kenichiro Inoue; Masatoshi Kiuchi; Susumu Hirase; Kenji Chiba; Hiroshi Sakamoto; Masafumi Arita
The Journal of Antibiotics | 1994
Shgeo Sasaki; Ryouta Hashimoto; Masatoshi Kiuchi; Kenichiro Inoue; Takeshi Ikumoto; Ryoji Hirose; Kenji Chiba; Yukio Hoshino; Takeki Okumoto; Tetsuro Fujita
The Journal of Antibiotics | 1996
Tetsuro Fujita; Norimitsu Hamamichi; Masatoshi Kiuchi; Tohru Matsuzaki; Yuki Kitao; Kenichiro Inoue; Ryoji Hirose; Masahiko Yoneta; Shigeo Sasaki; Kenji Chba
Archive | 1999
Susumu Hirase; Shigeo Sasaki; Masahiko Yoneta; Ryoji Hirose; Tetsuro Fujita
Chemical & Pharmaceutical Bulletin | 2008
Norimasa Matsumoto; Ryoji Hirose; Shigeo Sasaki; Tetsuro Fujita
Bioorganic & Medicinal Chemistry | 2006
Norimasa Matsumoto; Takeyuki Kohno; Shuji Uchida; Takaaki Shimizu; Haruko Kusumoto; Ryoji Hirose; Kazuo Yanada; Wasako Kurio; Shoji Yamaguchi; Kazuhito Watabe; Tetsuro Fujita